Eli Lilly (NY:LLY)Headline News about Eli LillyVia Benzinga
Via Benzinga
Eli Lilly's Zepbound Outperforms Wegovy In New Obesity Trial, But Trump's Drug Pricing Plan Keeps Retail Traders Wary
May 11, 2025
Via Stocktwits
Topics
Government
Exposures
Political
Via The Motley Fool
Via Benzinga
4 No-Brainer Stocks to Buy Right Now
May 09, 2025
Via The Motley Fool
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks
May 08, 2025
Via Benzinga
Exposures
Political
Via The Motley Fool
Via Benzinga
Exposures
Product Safety
Novo Nordisk's Wegovy Sales Surge 85% But Compounded Weight Loss Drugs In US Impacts Annual Outlook
May 07, 2025
Via Benzinga
Topics
Earnings
Exposures
Financial
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|